Comparison of the effects of Liraglutide, Tirzepatide, and Retatrutide on diabetic kidney disease in db/db mice.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Comparison of the effects of Liraglutide, Tirzepatide, and Retatrutide on diabetic kidney disease in db/db mice.
- Published In:
- Endocrine, 87(1), 159-169 (2025)
- Authors:
- Ma, Jun, Hu, Xiaoyan, Zhang, Wencheng, Tao, Mengyuan, Wang, Min, Lu, Weiping
- Database ID:
- RPEP-12363
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12363APA
Ma, Jun; Hu, Xiaoyan; Zhang, Wencheng; Tao, Mengyuan; Wang, Min; Lu, Weiping. (2025). Comparison of the effects of Liraglutide, Tirzepatide, and Retatrutide on diabetic kidney disease in db/db mice.. Endocrine, 87(1), 159-169. https://doi.org/10.1007/s12020-024-03998-8
MLA
Ma, Jun, et al. "Comparison of the effects of Liraglutide, Tirzepatide, and Retatrutide on diabetic kidney disease in db/db mice.." Endocrine, 2025. https://doi.org/10.1007/s12020-024-03998-8
RethinkPeptides
RethinkPeptides Research Database. "Comparison of the effects of Liraglutide, Tirzepatide, and R..." RPEP-12363. Retrieved from https://rethinkpeptides.com/research/ma-2025-comparison-of-the-effects
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.